Daily Target 2X Long MRNA ETF (MRNX) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Daily Target 2X Long MRNA ETF (MRNX) operates in the Financial Services sector, specifically the Asset Management - Leveraged industry, with a market capitalization near $1.6M, listed on AMEX, carrying a beta of -2.89 to the broader market. The MRNX fund is designed to generate returns by taking a leveraged, bullish stance on the daily share price movements of Moderna, Inc. Led by James Atkinson, public since 2026-02-04.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for MRNX as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →